Novo Nordisk's (NVO) obesity therapy Wegovy cut adverse kidney-related events by 22% in obese and overweight individuals in a ...
Certain genes may predict strong responses to Novo Nordisk's Wegovy (semaglutide) in obesity treatment, with patients showing ...
In a letter to Bernie Sanders, Novo Nordisk said it only retains 60% of the list price of either Ozempic or Wegovy ...
Amid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and Zepbound, one question has ...
Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk's weight-loss drug ...
A recent clinical trial of Wegovy showed that 17 percent of patients on the drug left the trial because of side effects.
A spokeswoman for Novo Nordisk, which markets Saxenda and Wegovy, declined to comment on the study, which has not been published in an independent medical journal. This class of weight-loss ...
New research shows Novo Nordisk's (NVO) weight loss drug, semaglutide, reduces the risk of death by 20% in patients with ...
Novo Nordisk (NVO) claims it retains only 60% of list price of weight loss drugs Ozempic and Wegovy after payments to pharma ...
Amid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and Zepbound, one question has ...
Nestlé CEO Mark Schneider said appetite suppressing GLP-1 drugs like Ozempic, Wegovy and Mounjaro create an opportunity for ...
A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four ...